Supplementary Modules part 2 (SM4-6)

Laboratory Testing & Patient Management (SM4)

This module is made up of three presentations.

Full module description SM4

Learning Outcomes
You will be expected to:

1. Describe and explain the role of clinically significant antibodies including monoclonal antibody therapies in the management of patient care, both antenatal and hospital patients and selection and ongoing provision of appropriate blood components to include the emergency setting.

2. Outline, describe and explain the causes of haemolytic disease of the fetus and newborn (HDFN). To describe, evaluate and recommend strategies for clinical management of women with clinically significant red cell antibodies in pregnancy, and the affected fetus/neonate including selection of blood components for intrauterine and exchange transfusion.

3. Describe and explain how to manage stem cell transplant patients. This will include the stages of transplant and how to manage blood provision throughout the transplant period.

4. Outline, describe and explain the causes of platelet refractoriness to include testing and management of patients.

5. Understand and explain the signs and symptoms of a blood transfusion reaction to include management of the patient and any associated recall and reporting associated with transfusion reactions.

Obstetric & Paediatric Transfusion Medicine (SM5)

This module is made up of two presentations.

Full module description SM5

Learning Outcomes
You will be expected to:

1. Understand the physiology of pregnancy and outline common causes of anaemia in pregnancy.

2. Outline the common haematological emergencies in pregnancy and describe their management including special transfusion requirements.

3. Have awareness of causes of obstetric haemorrhage and coagulopathy in pregnancy and appropriate use of transfusion support in management of obstetric haemorrhage and coagulopathy.

4. Describe the approach to the investigation of anaemia, thromobcyptopenia and coagulopathy in neonates and infants/children.

5. Understand and describe the indication for red cell, platelet and plasma transfusion in neonates, infants and children.  Explain the specialist blood components available for children <1 year of age.

Therapeutic Apheresis (SM6)

This module is made up of one presentation.

Full module description SM6

Learning Outcomes
You will be expected to:

1. Understand basic principles of Therapeutic Apheresis (TA) and national standards.

2. Describe the different apheresis treatments and their indications.

3. Understand considerations for therapeutic apheresis in relation to the procedure and the patient.

4. Explain how blood and blood products are used in therapeutic apheresis.

5. Have awareness of ongoing development in therapeutic apheresis and adjacent services.

Back to CTP Student Guide

Programme of Study